Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vibrating sleeves may help stroke patients move better

NCT ID NCT03298243

Symptom relief Sponsor: Marquette University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding gentle vibrations to the arm can help stroke survivors who have lost sense of position better control their movements. Thirty participants will perform reaching and daily tasks like drinking from a glass while wearing a device that provides extra sensory feedback. The goal is to see if this simple approach improves arm function and coordination.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * stroke survivors who can perform our stabilization and grip modulation tasks and who * had a single ischemic or hemorrhagic stroke of the middle cerebral artery (MCA) in the chronic state of recovery (\> 6 months post-stroke). * ability to give informed consent and be able to follow two-stage instructions. * mild-to-moderate motor impairment as assessed using the upper extremity (UE) portion of the Fugl-Meyer Motor Assessment (FM); i.e., UE-FM score between 28 and 50 (inclusive) out of a possible 66. * proprioceptive deficit at the elbow in the more involved (contralesional) arm. * preserved tactile sensation in either the ipsilesional arm and/or thigh. * a minimal active wrist extension of 5°. Exclusion Criteria: * Inability of subjects to give informed consent or follow two-stage instructions. * subjects with a bleeding disorder. * subjects with fixed contractures or a history of tendon transfer in the involved limb. * subjects with a diagnosis of myasthenia gravis, amyotrophic lateral sclerosis or any disease that might interfere with neuromuscular function. * subjects who are currently using or under the influence of aminoglycoside antibiotics, curare-like agents, or other agents that may interfere with neuromuscular function. * subjects with a history of epilepsy. * history of other psychiatric co-morbidities (e.g. schizophrenia). * malignant or benign intra-axial neoplasms. * concurrent illness limiting the capacity to conform to study requirements. * Cardiac pacemaker, cardiac arrhythmia or history of significant cardiovascular or respiratory compromise. * subjects with profound atrophy or excessive weakness of muscles in the target area(s) of testing. * subjects with a systemic infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Proprioceptive disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Somatosensory Disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Proprioceptive disorders Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Marquette University

    RECRUITING

    Milwaukee, Wisconsin, 53233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.